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Results: 
  
In fields 10 to 30 mm the measured Sc using all dosimeter types with 
all miniphantoms agree to within 1%. For fields below 10 mm, the 
measured Sc decreases with increase in the top width. This is because 
the entire miniphantom is no longer in the high dose region of the 
field and the scatter from the buildup material is no longer constant 
across all measurements. The 3 mm top was considered to be the best 
compromise to measure Sc in small fields, since a smaller top 
introduced large geometric uncertainties. For all dosimeters, in 
conjunction with the 3 mm top, the measured Sc agreed within 1% for 
fields larger than 10 mm. For fields below 10 mm the agreement was 
within 2.3%. 
Conclusions: The miniphantom design critically affects measured 
output factors in air, while the dosimeter type is not as crucial, as 
long as the active volume is small compared to the field size. For field 
sizes 30 mm or less, we recommend the use of a 3 mm wide 
miniphantom with no sidewalls and dmax equivalent height. 
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Purpose/Objective: To rationalize quality management in IMRT pre-
treatment verification, in a meeting of our Societyf or Medical Physics 
it was proposed to investigate which IMRT plans are more prone to 
error and should be pre-treatment verified and which not based on 
the complexity of the plan. Therefore, it was proposed to create a 
national database in which all patient IMRT plans and pre-treatment 
verification results would be included. Consistency amongst data 
entered by the different centre had to be guaranteed. This paper 
presents the inter-comparison on pre-treatment v erification methods 
and results amongst the different centres participating inthe study. 
The in-house verification methods are compared to the results of an 
external audit. 
Materials and Methods: Six departments with different linac brands 
participated in the study. The TPS were Eclipse, Oncentra MasterPlan 
and iPlan. The pre-treatment verification equipment and methods 
were based on EPID dosimetry, radiochromic films, detector 2D 
arrays. 
The centres were asked to use two of the AAPM TG119 cases (prostate 
and head and neck) to commission their IMRT planning and delivery 
systems for IMRT. In addition an external audit was performed so that 
the gamma pass rates reported by the centre using their equipment 
and methodology were compared to those using the same system, 
Mapcheck 2 array, through all the centres. The obtained results were 
also compared to those reported in TG 119.  
The compliance to the dosimetry goals proposed by the TG as well as 
the dosimetry parameters (ICRU 83) and total number of MU per plan 
were collected. A quality index ([D98(PTV)-D98TG(PTV)]+[D20TG(PTV)- 
D20(PTV)]+Σi,x[DxTG(OARi)-Dx(OARi)]) to compare the different plans is 
proposed. 
Results: All plans fulfiled the dosimetric requirements in TG119 for 
the prostate case with the exception of one centre not reaching the 
D95 requirement for the head and neckcase. The number of MU was 
highly dependent on the treatment technique, being 1/4 for the step 
and shot technique, leaf thickness, to the experience of the centre 
and the optimisation algorithm. There was a wide range of total MU 
needed for the head and neck plan within the centres using sliding 
windows technique (588MU-1695MU), which did not correlate to the 
plan quality index (0.114-0.448). 
The summary of the results of both the on-site pre-treatment 
measures as well as the audit are shown in Table I. 
 Due to discrepancies between the on-site system and the external 
audit two centers modified their routine pre-treatment verification 
procedures. 
Conclusions 
1. The use of pre-treatment pass rates using on-site methods and 
equipment for a global data base is not recommended if they 
have not been validated by an external audit. 
2. An agreement on the gamma method (normalisation, threshold, 
etc) has to be required.  
3. External audits cannot be substituted by on-site validations. 
4. There is a need of a quality index as a metric for IMRT plan 
quality. Fulfilment of the dosimetric constrains is not enough. 
5. The dosimetry quality index does not correlate with the total 
number of MU per plan.  
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Purpose/Objective: Medical physicists in low and middle income 
countries often do not have access to national medical physics post-
graduate academic education, clinical training or certification 
programs, a situation which can potentially compromise the quality 
and safety of radiotherapy. To compound this problem, these 
physicists generally do not have English as their first language, 
preventing them from making effective use of English language text-
based training resources.  
To reduce the risk of calibration-related errors we have developed a 
novel graphics-based tool to enhance understanding of the IAEA TRS 
398 Code of Practice on Absorbed Dose Determination in External 
Beam Radiotherapy, which is published in English, Russian and Spanish 
only. The intention is not to diminish the need for conventional 
education in medical physics, but until such programmes are 
established interim training resources are required to support the 
physicists already working in clinics. 
A secondary objective of the project is to provide physicists with a 
way of demonstrating to hospital managers or administrators what 
resources (personnel and equipment) are required to maintain a 
reasonable safety standard.  
Materials and Methods: The teaching tool avoids jargon and 
abbreviations, but assumes that fundamental radiation dosimetry 
principles are already known. The text is combined with photos, 
animated illustrations and video footage demonstrating a physicist 
setting up the measuring equipment, taking the measurements etc. 
The text and graphics were created in Powerpoint and then published 
for the web with the embedded videos using Articulate Presenter. 
Presenter provides features such as a hyperlinked contents panel, a 
glossary, a search function and the ability for the viewer to pause the 
presentation, which is a significant advantage for a non-English 
speaker who may need longer to read the text. No software is 
required to view the presentation other than an internet browser. 
Results: Excerpts from the training materials will be presented and 
the challenges of the project will be discussed. Considerations 
included whether to recommend one calibration method only or to 
illustrate multiple alternative methods and how to accommodate 
centres that may have very limited dosimetry and QA equipment.  
Conclusions: This novel approach to teaching a difficult but important 
subject provides a resource to support clinical medical physicists in 
low and middle income countries. The potential significance of this is 
a reduction of systematic errors in absolute dosimetry in radiotherapy. 
This tool will be made freely available for download from the IAEA's 
Human Health Campus website.  
 
 
 
 
 
